Literature DB >> 23103083

Lenalidomide is effective for the treatment of bortezomib-resistant extramedullary disease in patients with multiple myeloma: report of 2 cases.

Chisako Ito1, Yoshinobu Aisa, Ai Mihara, Tomonori Nakazato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23103083     DOI： 10.1016/j.clml.2012.08.005

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN： 2152-2669


× No keyword cloud information.
  6 in total

Review 1.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

2.  Successful treatment with lenalidomide of secondary multiple myeloma with extramedullary liver plasmacytoma in a renal transplant recipient: A case report and review of the literature.

Authors:  Xiaobao Xie; Wei Wu; Yuandong Zhu; Deliang Liu; Weimin Dong; Haiqian Li; Qing Li; Weiying Gu
Journal:  Oncol Lett       Date:  2015-09-18       Impact factor: 2.967

Review 3.  Extramedullary plasmacytoma mimicking colon carcinoma: an unusual presentation and review of the literature.

Authors:  Kaela Parnell; Mashrafi Ahmed; Roger D Smalligan; Suhasini Nadesan
Journal:  BMJ Case Rep       Date:  2015-10-23

4.  Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma.

Authors:  Andrew C Tiu; Rashmika Potdar; Vivian Arguello-Gerra; Mark Morginstin
Journal:  Case Rep Hematol       Date:  2018-05-24

Review 5.  Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance.

Authors:  Vincenzo Sammartano; Alfonso Cerase; Valentina Venanzi; Maria Antonietta Mazzei; Beatrice Esposito Vangone; Francesco Gentili; Ivano Chiarotti; Monica Bocchia; Alessandro Gozzetti
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

6.  Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome: combined molecular and therapeutic studies.

Authors:  Lourdes Farre; Gabriela Sanz; Neus Ruiz-Xivillé; Manuel Castro de Moura; Juan Francisco Martin-Tejera; Samuel Gonçalves-Ribeiro; Maria Martinez-Iniesta; Monica Calaf; Jose Luis Mosquera; José Ignacio Martín-Subero; Isabel Granada; Manel Esteller; Eva Domingo-Domenech; Fina Climent; Alberto Villanueva; Anna Sureda
Journal:  Dis Model Mech       Date:  2021-07-15       Impact factor: 5.758
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.